CNS Pharmaceuticals, Inc.

Form D Filings

Location
Houston, TX
Industry Group
Pharmaceuticals
Entity Type
Corporation
CIK
0001729427
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
5/19/2026 Equity, Option to Acquire $22,525,000 $22,525,000 $0 5/4/2026 5/19/2026 D 000168316826004126